- Church Of Scientology Celebrates A Decade Of Expansion Under The Leadership Of David Miscavige
- Tesla Motors Stock Will Sell Off Into 2016 but then Stage a Huge Rally to $500
- Why College Isn't Worth It, No Matter How Rich or Poor You Are
- Here's Why the Microsoft Surface Pro 4 Is Better Than the iPad Pro
- GM Gets Another Chance With Chevrolet Malibu Midsize Sedan
We've found four beaten-down income generators that trade at attractive valuations, but they're positioned to take off in 2016. Here's why these bargains belong in your dividend portfolio now.
12/01/15 - 08:12 AM EST
We look at the real story behind the recent plunge of this multinational energy company's stock and gauge whether it's a hidden bargain heading into 2016.
11/30/15 - 03:07 PM EST
BlackBerry's first Android smartphone faces a steep uphill battle against the luxury-priced competition
11/30/15 - 12:51 PM EST
Here are five stocks that churn out robust income, year in and year out. They've consistently grown dividends, a record they're on the verge of repeating in 2016.
11/30/15 - 12:45 PM EST
Our top picks include a big $4,000 desktop and a new $5, bare-bones design.
11/30/15 - 10:24 AM EST
Here are the 11 the best smartphones of the year.
11/30/15 - 09:41 AM EST
These three income generators are currently under-appreciated, which makes them great bargains for yield-hungry investors who act now.
11/27/15 - 02:45 PM EST
TeleCommunication Systems Inc. said Monday it has agreed to sell to Comtech Telecommunications Corp. in a transaction with an enterprise value of $430.8 million.
11/23/15 - 03:58 PM EST
Network and cable TV providers are cutting back on ad time, but finding new ways to make more money.
11/23/15 - 06:11 AM EST
- Tickers in this article:
After years of being a leading tech company, is Apple's stock still going strong?
11/22/15 - 06:55 PM EST
As Forrest Gump might say, in surveying this sampling of predictions from the business world's supposedly astute players: 'Stupid is, as stupid does.'
11/21/15 - 09:59 AM EST
Jim Cramer, portfolio manager of the TheStreet's Action Alerts PLUS, said based on valuation investors should buy Allergan over Pfizer.
11/20/15 - 03:10 PM EST